Catherine Skari

Renal Dysfunction in Pediatric Patients in Iraq With β-Thalassemia Major and Intermedia

Background: With optimum transfusion and chelation therapy, the survival of β-thalassemia patients and the incidence of various complications, including renal…

Read More »

NEWSLETTER | Iranian Blood Transfusion Organization (IBTO) August 2022

Read More »

SAFER BLOOD | EU Patients Have Begun Receiving Transfusions With Hemanext ONE® RBC Processing & Storage System

Doctors have begun transfusing patients suffering from hematological malignancies using RBCs processed and stored with the Hemanext ONE® system, as part…

Read More »

Precision Medicine and Sickle Cell Disease

Sickle cell disease (SCD) is characterized by variable clinical outcomes, with some patients suffering life-threatening complications during childhood, and others…

Read More »

Does Hepcidin Tuning Have a Role Among Emerging Treatments for Thalassemia?

The treatments available for thalassemia are rapidly evolving, with major advances made in gene therapy and the modulation of erythropoiesis.…

Read More »

WORLD PATIENT SAFETY DAY 2022 | Medication Without Harm: Know. Check. Ask.

Read More »

SICKLE CELL DISEASE | African Health Ministers Launch Drive to Curb SCD’s Toll

This effort, backed by the African Regional Office of the World Health Organization (WHO), aims to curb SCD΄s toll in…

Read More »

A HISTORIC BREAKTHROUGH | UNICEF Signs First-Ever Malaria Vaccine Supply Contract With GSK

The contract will enable UNICEF to deliver more than 18 million doses of the RTS,S vaccine – also known under…

Read More »

In Vivo Base Editing by a Single Intravenous Vector Injection for Treatment of Hemoglobinopathies

Individuals with β-thalassemia or Sickle Cell Disease and hereditary persistence of fetal hemoglobin (HPFH) possessing 30% HbF appear to be…

Read More »

Luspatercept for the Treatment of Anaemia in Non-Transfusion-Dependent β-Thalassaemia (BEYOND): A Phase 2, Randomised, Double-blind, Multicentre, Placebo-controlled Trial

Background In patients with non-transfusion-dependent β-thalassaemia, haemoglobin concentrations lower than 10 g/dL are associated with a higher risk of morbidity,…

Read More »